http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2012268892-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21026ae5fccc14c2369a54b0d7d211ca |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
filingDate | 2012-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b7ff3b31a1602ea706655252673fae3 |
publicationDate | 2016-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2012268892-B2 |
titleOfInvention | Method of Treating Patients with a Mucinous Glycoprotein (MUC-1) Vaccine |
abstract | C:\NRPobi\DCC\SCG\4833925_I.DOC-24/12/2012 The present invention provides a method for treating an individual who is afflicted with a cancer, by administering to that individual a MUC-1 -based formulation. The formulation may be a MUC-1 based liposomal vaccine formulation. |
priorityDate | 2005-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 230.